Skip to main content
APPLY

GLP-1

What Happens After GLP-1 Treatment Stops?

The STEP 1 extension followed participants after treatment withdrawal and found substantial average weight regain. The finding describes a cohort, not an individual destiny.

Why the distinction matters

Stopping is a decision people make, and the evidence about stopping is frequently quoted at them as either a warning or a permission. It is neither. It is an observation about what a specific trial population did on average after treatment was withdrawn.

What the source actually reports

  • One year after withdrawal, participants regained approximately two-thirds of their prior mean weight loss.
  • Cardiometabolic variables also moved back toward baseline.
What the extension observed

Two observations reported by the off-treatment extension one year after treatment withdrawal in the STEP 1 population.

  • Mean weight loss≈ two-thirds regained

    One year after withdrawal, participants regained approximately two-thirds of their prior mean weight loss.

  • Cardiometabolic variablesMoved toward baseline

    Also moved back toward baseline in the extension population.

What this can support

  • Understanding that treatment withdrawal was followed and measured, not assumed.
  • Framing a conversation about what happens after, before treatment begins.

What it cannot support

  • Telling any reader to continue or discontinue medication.
  • Tapering, dose or maintenance instructions.
  • Predicting what any individual would regain or retain.

Questions to take to a licensed clinician

  1. 01If treatment ever stops, what is the plan, and who monitors it?
  2. 02What would we measure after stopping, and over what period?
  3. 03How does this evidence apply — or not apply — to my situation?

Decisions about starting, continuing, changing or stopping any medication belong with an appropriate licensed clinician who knows your history.

The free guide explains how the system approaches decisions like these — measurement first, structure before intensity, ownership at the end.

Get the Ascendant Goodies

Sources

Sources last checked

Written by

AbtinFounder, Ascendant Health

The position

GLP-1 medications can be effective. The difference between trial outcomes and everyday outcomes often exposes an execution and adherence problem.

GLP-1 outcomes

Related reading

GLP-1Trial Results Are Not Personal Forecasts: Reading STEP 1 CorrectlyGLP-1Why GLP-1 Results in Real Life Differ From Clinical TrialsGLP-1Weight Loss and Lean Mass: What Body-Composition Research Actually Shows

This article is general education. It is not medical advice, a diagnosis or treatment guidance, and it does not recommend for or against any medication, protocol or provider. Decisions about your health belong with a qualified professional who knows your history.

Ascendant Health is a coaching service. It does not practise medicine or prescribe.